Vimarsana
Biggest News Aggregation in the World

Page 13 - Consolidated Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consolidated Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consolidated Statement Today - Breaking & Trending Today

Eventbrite Reports First Quarter 2024 Financial Results - Vimarsana News

Eventbrite Reports First Quarter 2024 Financial Results

First quarter revenue of $86.3 million grew 11% year-over-year Marketplace revenue from non-ticketing sources exceeded 13% of first quarter revenue Consumer reach extended to over 27 million with...

Eventbrite Reports First Quarter 2024 Financial Results - Vimarsana News

Eventbrite Reports First Quarter 2024 Financial Results

Eventbrite , a global marketplace for shared experiences, reported its financial results for the first quarter ended March 31, 2024. The First Quarter 2024 Shareholder Letter can be found on Eventbrite's Investor Relations website at...

DuPont Reports First Quarter 2024 Results - Vimarsana News

DuPont Reports First Quarter 2024 Results

Net Sales of $2.9 billion decreased 3%; organic sales decreased 6% versus year-ago period GAAP Income from continuing operations of $183 million; operating...

BlackRock TCP Capital Corp. Announces First Quarter 2024 Financial Results; Declares Second Quarter Dividend of $0.34 Per Share; 12 Years of Consistent Quarterly Dividend Coverage - Vimarsana News

BlackRock TCP Capital Corp. Announces First Quarter 2024 Financial Results; Declares Second Quarter Dividend of $0.34 Per Share; 12 Years of Consistent Quarterly Dividend Coverage

BlackRock TCP Capital Corp. , a business development company , today announced its financial results for the first quarter ended March 31, 2024 and filed its Form 10-Q with the U.S. Securities and...

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024 - Vimarsana News

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024

HARMONi and HARMONi-3 Enrollment Continues Promising Intracranial Anti-Tumor Activity and Safety Data Featured at the 2024 European Lung Cancer Congress with Ivonescimab Alone or Combined with...